Article
TP53 mutations in human skin cancers.
Human mutation - 1 Mar 2003
Giglia-Mari Giuseppina, Sarasin Alain
Abstract excerpt
The p53 gene (TP53) is mutated in numerous human cancers. We have used it as a molecular target to characterize the induction of mutations in human skin cancers. About 50% of all skin cancers in normal individuals exhibit p53 mutations. This frequency rises to 90% in skin cancers of patients with the DNA-repair deficiency known as xeroderma pigmentosum (XP). These mutations are characterized by a specific...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
